Virpax Pharmaceuticals, Inc. (VRPX) DCF Valuation

Virpax Pharmaceuticals, Inc. (VRPX) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Virpax Pharmaceuticals, Inc. (VRPX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to determine the intrinsic value of Virpax Pharmaceuticals, Inc.? Our VRPX DCF Calculator integrates real-world data with comprehensive customization options, allowing you to refine your forecasts and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -4.2 .0 .0 -15.2 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 3.2 4.2 12.0 18.3 .5 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -3.2 -8.4 -12.0 -18.3 -15.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 .1 36.8 19.0 9.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -3.3 -8.7 -12.1 -18.2 -15.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -.1 -4.5 -.1 .2 -15.2 .0 .0 .0 .0 .0
WACC, % 9.62 9.62 9.62 9.62 9.62 9.62 9.62 9.62 9.62 9.62
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -9
Equity Value 9
Diluted Shares Outstanding, MM 1
Equity Value Per Share 7.81

What You Will Get

  • Real Virpax Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Virpax’s fair value.
  • Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
  • Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.

Key Features

  • Comprehensive Financial Data: Gain access to precise historical figures and future forecasts for Virpax Pharmaceuticals, Inc. (VRPX).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: Utilize user-friendly charts and summaries to effectively visualize your valuation findings.
  • Designed for All Users: A straightforward, intuitive layout tailored for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Virpax Pharmaceuticals' (VRPX) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the updated results, including Virpax Pharmaceuticals' intrinsic value.
  • Step 5: Make well-informed investment choices or create reports based on the outputs.

Why Choose This Calculator for Virpax Pharmaceuticals, Inc. (VRPX)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your specific analysis needs.
  • Real-Time Feedback: Instantly observe changes to Virpax’s valuation as you modify inputs.
  • Pre-Loaded Data: Comes equipped with Virpax’s actual financial information for swift evaluations.
  • Endorsed by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Virpax Pharmaceuticals stock (VRPX).
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models tailored for the pharmaceutical industry.
  • Consultants: Deliver professional valuation insights to clients in the healthcare sector quickly and accurately.
  • Business Owners: Understand how pharmaceutical companies like Virpax are valued to guide your own business strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios specific to the pharmaceutical market.

What the Template Contains

  • Historical Data: Includes Virpax Pharmaceuticals’ past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Virpax Pharmaceuticals’ intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Virpax Pharmaceuticals’ financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.